New weekly fertility injections work as well as daily

New long-lasting weekly injections of fertility hormones are as safe and effective as standard daily injections, according to Cochrane researchers. The researchers compared weekly and daily hormone injections in a Cochrane systematic review and found no difference in pregnancies or serious side effects between the two regimens.

Women undergoing are usually given daily injections of follicle stimulating hormone (FSH) to increase the number of eggs that their ovaries release each month. In in vitro (IVF) and (ICSI), the eggs are then removed and fertilised outside the body. Daily hormone injections can be painful and stressful but a new longer-lasting FSH, known as corifollitropin alfa, has recently been introduced. One injection of this longer-lasting hormone can replace the first seven days of FSH injections required in the standard .

The researchers included data from four trials involving 2,335 people in their review. They show that women given medium doses of the new long-lasting hormone on a weekly basis are equally likely to become pregnant and are no more likely to have a miscarriage or than those receiving daily FSH injections.

"These results show that the new long-acting injections are a safe treatment option and equally effective in medium doses compared to the standard daily injections," said Jan Kremer, one of the authors of the review based at the Radboud University Nijmegen Medical Center in Nijmegen, Netherlands.

However, there is currently limited information about with long-lasting FSH. "One of the main reasons weekly injections are considered preferable to daily injections is that they are more patient friendly," said Kremer. "So are couples undergoing fertility treatment happier with weekly injections? We would like to see research addressing this question."

Further research is also needed to establish whether long-acting injections are as effective in women who respond poorly to fertility hormones and those who 'hyperrespond', meaning they produce higher than expected numbers of eggs.

More information: Pouwer AW, Farquhar C, Kremer JAM. Long-acting FSH versus daily FSH for women undergoing assisted reproduction. Cochrane Database of Systematic Reviews 2012, Issue 6. Art. No.: CD009577. DOI: 10.1002/14651858.CD009577.pub2

add to favorites email to friend print save as pdf

Related Stories

Researchers develop long-lasting growth hormone

Sep 04, 2007

Researchers at the University of Sheffield have developed a long-acting growth hormone for use in human therapy. The new discovery could mean that children and adults with growth hormone disorders will not have to have injections ...

BPA lowers male fertility: report

Jun 06, 2011

Daily exposure to a chemical that is prevalent in the human environment, bisphenol A (BPA), causes lowered fertility in male mice, according to the results of a new study that will be presented Saturday at The Endocrine Society's ...

Recommended for you

Triglycerides significantly elevated in women with GDM

12 hours ago

(HealthDay)—For women with gestational diabetes mellitus (GDM), triglycerides are significantly elevated throughout pregnancy, according to a review published online Jan. 22 in BJOG: An International Jo ...

Safer childbirth for women everywhere

19 hours ago

Few women in developed countries die of blood loss in childbirth, but in remote areas and developing countries, an estimated 100,000 die every year from post-partum haemorrhage. 

10 tips to prepare for pregnancy

22 hours ago

For women of childbearing age looking to become pregnant, it is never too early to engage in healthy habits to ensure that she has a healthy pregnancy and her child has a healthy first step.

AAFP advocates for planned vaginal birth after cesarean

Jan 28, 2015

(HealthDay)—A planned labor and vaginal birth after cesarean (LAC/VBAC) is an appropriate option for most women with a history of prior cesarean birth, according to a clinical practice guideline published ...

Women diagnosed with PCOS twice as likely to be hospitalized

Jan 27, 2015

Women diagnosed with polycystic ovary syndrome - the most common hormone disorder in women of reproductive age - face a heightened risk of developing heart disease, diabetes, mental health conditions, reproductive disorders ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.